Atopic eczema between rationality and irrationality

Archives of Dermatology

Volumn 134, Issue 11, 1998, Pages 1462-1469

  Ruzicka, Thomas ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ATOPIC DERMATITIS; CORTICOSTEROID THERAPY; GENETIC PREDISPOSITION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0031724664     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.11.1462     Document Type: Review

References (38)

1. Rothe MJ, Grant-Kels JM. Atopic dermatitis: an update. J Am Acad Dermatol. 1996;35:1-13.
2. Wüthrich B. Epidemiology and natural history of atopic dermatitis. ACI Int. 1996; 8:77-82.
3. Kissling S, Wüthrich B. Verlauf der atopischen Dermatitis nach dem Kleinkindalter. Hautarzt. 1993;44:569-573.
4. Ruzicka T, Ring J, Przybilla B. Handbook of Atopic Eczema. Heidelberg, Germany: Springer-Verlag; 1991.
5. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol. 1994;102:128-137.
6. Leung DYM. Immunopathology of atopic dermatitis. Springer Semin Immunopathol. 1992;13:427-440.
7. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol. 1995;96:302-319.
8. Ruzicka T, Geltinger S. High prevalence of atopy suggesting a role as co-factor in the clinical manifestation of condylomata acuminata. J Eur Acad Dermatol. 1995;4:224-229.
9. Wüthrich B. Neurodermitits atopica sive constitutionalis: ein pathogenetisches Mode aus der Sicht des Allergologen. Aktuelle Dermatol. 1983;9:1-7.
10. Bruijnzeel-Koomen C, van Wichen DF, Siraganian RP, Toonstra J, Berends L, Bruijnzeel PLB. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res. 1986;287:100-105.
11. Ring J, Kunz B, Bieber T, Vieluf D, Przybilla B. The "atopy patch test" with aero-allergens in atopic eczema. J Allergy Clin Immunol. 1989;83:195-199.
12. Hanifin JM. Atopic dermatitis. J Allergy Clin Immunol. 1984;73:211-222.
13. Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D. Skin: nervous system interactions. J Invest Dermatol. 1996;106:198-204.
14. Hosoi J, Murphy GF, Egan CL, et al. Regulation of Langerhans cell function by nerves containing calcitonis gene-related peptide. Nature. 1993;363:150-163.
15. Mao XQ, Shirakawa T, Yoshikawa T, et al. Association between genetic variants of mast-cell chymase and eczema [published erratum appears in Lancet. 1997; 349:641]. Lancet. 1996;348:581-583.
16. Bayerl CH, Jung EG. Neurodermitis prnventive und therapeutische Strategien einer Umweltdermatose. Akt Dermatol. 1996;22:289-305.
17. Young E, Patel S, Stoneham M, et al. The prevalence of reaction to food additives in a survey population. J R Coll Physicians Lond. 1987;21:241-247.
18. Lehmann P. Corticosteroid contact dermatitis. Dermatosen Occup Environ. 1997; 45:116-120.
19. Neuber K, Koenig W, Ring J. Staphylococcus aureus und atopisches Ekzem. Hautarzt. 1993;44:135-142.
20. Przybilla B, Ebedein-Konig B, Rueff F. Practical management of atopic eczema. Lancet. 1994;343:1342-1345.
21. Korting HC, Kerscher MJ, Schafer-Korting M. Topical glucocorticoids with improved benefit-risk ratio: do they exist? J Am Acad Dermatol. 1992;27:87-92.
22. Sampson HA. Relationship between food-specific IgE concentration and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. 1997;100:444-451.
23. Artherton DJ, Sewell M, Soothil JF, Wells RS, Chilvers, CE. A double-blind controlled crossover trial of an antigen-avoidance diet in atopic eczema. Lancet. 1978;1: 401-403.
24. Przybilla B, Ring J. Food allergy and atopic eczema. Semin Dermatol. 1990;9: 220-225.
25. Fuglsang G, Madsen C, Halken S, Jorgensen M, Ostergaard PA, Osterballe O. Adverse reactions to food additives in children with atopic symptoms. Allergy. 1994;49:117-132.
26. Krutmann J. Phototherapy for atopic dermatitis. Dermatol Ther. 1996;1:24-31.
27. Richter HI, Billmann-Eberwein C, Grewe M, et al. Successful monotherapy of severe and intractable atopic dermatitis by photopheresis. J Am Acad Dermatol. 1998;38:585-588.
28. Kagi M, Zurbriggen B, Burg G, Wutherich B. Treatment of atopic dermatitis with a new galenical formulation of cyclosporin A (Neoral): monitoring the clinical activity with serological parameters. Dermatology. 1996;193:163-168.
29. Zoneveld IM, de Rie MA, Bejaards RC, et al. The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimes. Br J Dermatol. 1996;135:15-20.
30. Berth-Jones J, Finlay AY, Zaki I, et al. Ciclosporin in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol. 1996;34:1016-1021.
31. Ruzicka T, Bieber T, Schopf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med. 1997;337:816-821.
32. Ruzicka T, Assmann T, Homey B. Tacrolimus (FK 506): the drug for the turn of the millenium? Arch Dermatol. In press.
33. Melnik BC, Plewig G. Is the origin of atopic dermatitis linked to deficient conversion of ω-6-fatty acids to prostaglandin E? J Am Acad Dermatol. 1989;21:557-563.
34. Sheehan MP, Atheron DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol. 1992;126:179-184.
35. Ferguson JE, Chalmers RJG, Rowlands DJ. Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol. 1997;136:592-593.
36. Chan TYK, Chan JCN, Tomlinson B, Critchley JAJH. Chinese herbal medicines revisited: a Hong Kong perspective. Lancet. 1993;32:1532-1534.
37. Schoni MH, Nikolaizik WH, Schoni-Affofter F. Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol. 1997;112:238-246.
38. Saarinen UM, Kajosnaari U. Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old. Lancet. 1995;346: 1065-1069.